The use of bacterial phage-associated lysing proteins for...

Details The use of bacterial phage-associated lysing proteins for... The use of bacterial phage-associated lysing proteins for...

A - Human Necessities

61

K

A61K 38/46 (2006.01) A23K 1/165 (2006.01) A23L 1/30 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2513571

A composition and method for treating bacterial infections by the use of an effective amount of at least one lytic specific for the bacteria causing specific. The lytic enzyme is genetically coded for by a bacteriophage which may be specific for said bacteria. The enzyme may be at least one lytic protein or peptides in a natural or modified form.

L'invention concerne une composition et un procédé de traitement d'infections bactériennes consistant à utiliser une quantité efficace d'au moins une lyse spécifique de la bactérie provoquant l'infection spécifique. L'enzyme lytique est génétiquement codée par un bactériophage qui peut être spécifique de ladite bactérie. L'enzyme peut être au moins une protéine lytique ou des peptides sous forme naturelle ou modifiée.

Affiliated with

Also associated with

Rating

The use of bacterial phage-associated lysing proteins for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of bacterial phage-associated lysing proteins for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of bacterial phage-associated lysing proteins for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1504621